Arjang Djamali

Title: Arjang Djamali: Innovator in Biomarker Detection

Introduction

Arjang Djamali is a notable inventor based in Cross Plains, Wisconsin. He has made significant contributions to the field of biomarker detection, particularly in the context of transplant medicine. His work focuses on improving the diagnosis and monitoring of antibody-mediated rejection in transplant recipients.

Latest Patents

Djamali holds a patent titled "Detection of B-cell activating factor as a biomarker for antibody mediated rejection in transplant recipients." This invention relates to methods, compositions, and kits for the detection of biomarkers. In one embodiment, the invention provides a method for detecting AMR biomarkers in a biological sample. Another embodiment details a method for detecting, monitoring, diagnosing, and predicting antibody-mediated rejection. Additionally, the invention includes a method for monitoring a subject for antibody-mediated rejection by detecting BAFF or a BAFF variant in a biological sample. Furthermore, it describes a kit for detecting BAFF in a urine sample. Djamali has 1 patent to his name.

Career Highlights

Djamali is associated with the Wisconsin Alumni Research Foundation, where he continues to advance research in biomarker detection. His innovative work has the potential to significantly impact the field of transplant medicine and improve patient outcomes.

Collaborations

Djamali has collaborated with notable colleagues, including Debra Bloom and Hans W. Sollinger, contributing to the advancement of research in his field.

Conclusion

Arjang Djamali's contributions to biomarker detection represent a significant advancement in the medical field, particularly for transplant recipients. His innovative methods and compositions are paving the way for improved diagnostic and monitoring techniques.